Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
RESEARCH TOOLSreports
Inhibikase Therapeutics (IKT) Technical Analysis
99 Followers
Technical Sentiment
Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Inhibikase Therapeutics’s (IKT) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Inhibikase Therapeutics is a Buy.
Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 1.39, while Inhibikase Therapeutics’s (IKT) share price is $1.16, making it a Sell.
Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 1.58, while Inhibikase Therapeutics’s (IKT) share price is $1.16, making it a Sell.
Inhibikase Therapeutics (IKT) Pivot Points
Classic
1.00
1.07
1.11
1.18
1.22
1.29
1.33
Fibonacci
1.07
1.12
1.14
1.18
1.23
1.25
1.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Inhibikase Therapeutics (IKT) Moving Averages
MA5
1.19Sell
1.21Sell
MA10
1.29Sell
1.28Sell
MA20
1.42Sell
1.39Sell
MA50
1.56Sell
1.58Sell
MA100
1.88Sell
1.72Sell
MA200
1.62Sell
1.71Sell
Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 1.28, while Inhibikase Therapeutics’s (IKT) share price is $1.16, making it a Sell.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.72, while Inhibikase Therapeutics’s (IKT) share price is $1.16, making it a Sell.
Inhibikase Therapeutics’s (IKT) stock price is $1.16 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.56, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.16 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.88, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.16 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.62, creating a Sell signal.
Inhibikase Therapeutics (IKT) Technical Indicators
RSI (14)
32.17
Neutral
STOCH (9,6)
11.11
Buy
STOCHRSI (14)
7.87
Buy
MACD (12,26)
-0.13
Buy
ADX (14)
25.60
Neutral
Williams %R
-94.12
Buy
CCI (14)
-104.83
Buy
ATR (14)
0.16
-
Ultimate Oscillator
31.47
Neutral
ROC
-24.18
Sell
Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 32.17, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 25.60, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is -104.83, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is -24.18, creating a Sell signal.
FAQ
Is IKT a Buy, Hold, or Sell?
Based on IKT’s technical indicators, IKT is a Sell.
What is IKT’s RSI (14)?
IKT’s RSI (14) is 32.17, which suggests IKT is a Neutral.
What is IKT’s MACD?
IKT’s MACD is -0.13, which suggests IKT is a Buy.
What is IKT’s 5-day moving average?
IKT’s 5-day moving average is 1.19, which suggests IKT is a Sell.
What is IKT’s 20-day moving average?
IKT 20-day moving average is 1.42, which suggests IKT is a Sell.
What is IKT’s 50-day moving average?
IKT’s 50-day moving average is 1.56, which suggests IKT is a Sell.
What is IKT’s 200-day moving average?
IKT’s 200-day moving average is 1.62, which suggests IKT is a Sell.
What is IKT’s Williams % R (14)?
IKT’s Williams % R (14) is -94.12, which suggests IKT is a Buy.
What is IKT’s CCI (14)?
IKT’s CCI (14) is -104.83, which suggests IKT is a Buy.